Print this page    •   Back to Web version of article

Commentary & Opinion
Africa Must Develop Its Own Pharmaceutical Pipeline Through Creation of Policy Frameworks

March 23, 2012

"To break free of its dependence on donor money and supplies from India, Africa must develop its own pharmaceutical pipeline by creating policy frameworks that encourage a fledgling drug industry," journalist Priya Shetty argues in this SciDev.Net opinion piece. "Although India's drug industry continues to churn out generics against killer diseases such as HIV/AIDS, malaria and tuberculosis, there is no end to resistance from global pharmaceutical companies wanting to extend the duration of market exclusivity on their brand-name drugs to prevent competition from generics," she writes, and notes, "The Council on Health Research for Development (COHRED) forum, to be held in South Africa in April 2012, will discuss how resource-poor nations can become more self-sufficient."

"There's another reason why African countries should experiment with developing a drugs industry -- the least-developed nations have until 2016 before they are bound by the international agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), which dictates patent protection for new drugs," she continues. "Africa will not bolster its pharmaceutical capacity without considerable incentive -- by subsidizing land to build manufacturing plants, for example, or reducing import taxes on chemicals -- from national governments, and perhaps from donors in the short term," she writes, concluding, "It will require extraordinary collaboration between industry and government agencies. But if it works, it will produce the most important set of public-private partnerships yet" (3/22).

Back to other news for March 2012

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.